Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Ono Pharmaceutical (4528 JP)
Watchlist
89
Analysis
Health Care
•
Japan
ONO PHARMACEUTICAL CO., LTD. manufactures and sells pharmaceuticals. The Company mainly researches and develops prescription drugs.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Ono Pharmaceutical
•
30 Apr 2024 21:12
Ono Pharmaceutical (4528 JP): Deciphera Acquisition Will Not Bring Immediate Respite
Ono Pharmaceutical will acquire Deciphera Pharmaceuticals for $25.60/share in cash. The total equity value of the acquisition is ~$2.4B. The...
Tina Banerjee
Follow
345 Views
Share
bullish
•
Ono Pharmaceutical
•
08 Nov 2023 01:20
Ono Pharmaceutical (4528 JP): Record H1 Earnings; Forxiga Is Flying High; FY24 Guidance Updated
Ono Pharma reported double-digit growth in revenue, operating profit, and net profit in H1FY24. The company has raised FY24 guidance by mid-to-high...
Tina Banerjee
Follow
471 Views
Share
bullish
•
Ono Pharmaceutical
•
01 Aug 2023 18:22
Ono Pharmaceutical (4528 JP): Mixed Q1 Result; Guidance Reiterated; Buyback Plan Announced
Ono recorded 13% YoY revenue growth to ¥120B in Q1FY24, driven by 12% YoY growth in product revenue. Lead drug, Opdivo reported 11% sales growth....
Tina Banerjee
Follow
248 Views
Share
bullish
•
Tokio Marine Holdings
•
21 May 2024 16:11
Tokio Marine Cross-Shareholding - At Least US$18bn of Cross-Shareholding to Sell
Tokio Marine today announced that it aims to cut its cross-shareholding to zero by FY2029. It will aim to sell 50% of its holdings worth around...
Sumeet Singh
Follow
764 Views
Share
bullish
•
MS&AD Insurance
•
21 May 2024 16:07
MS&AD Cross-Shareholding - At Least US$20bn of Cross-Shareholding to Sell
Along with its results announcement today, MS&AD announced that it will accelerate its cross-shareholding unwind and is targeting a sale of around...
Sumeet Singh
Follow
691 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.1
x